Mostrando 8,421 - 8,440 Resultados de 9,628 Para Buscar '"patentes"', tiempo de consulta: 0.18s Limitar resultados
  1. 8421
    “…From these, 284 duplicate records were eliminated, and an additional 895 records were excluded due to their association with patent applications, diagnostic tests, forensic analyses, or irrelevance to the research focus. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  2. 8422
    por Back, Liam, Ladwiniec, Andrew
    Publicado 2023
    “…SVGs are known to progressively degenerate over time and, even if they remain patent, demonstrate marked accelerated atherosclerosis. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  3. 8423
    “…RESULTS: NT was developed using patented algorithms combining 13 parameters: age, sex, height, weight, and serum levels of triglycerides, cholesterol, alpha2macroglobulin, apolipoprotein A1, haptoglobin, gamma-glutamyl-transpeptidase, transaminases ALT, AST, and total bilirubin. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Texto
  4. 8424
    “…Regarding the secretion of IL-8, three findings were patent: the strong basal secretion of this cytokine; the moderate increase induced by LPS; and the existence of significant differences among the different groups with respect to the stimulated secretion of this cytokine, which reached maximum values in patients with idiopathic pulmonary fibrosis. …”
    Enlace del recurso
    Enlace del recurso
    Texto
  5. 8425
    “…BACKGROUND: Following the Implementation of Paragraph 6 of the Doha Declaration on TRIPS and Public Health, Canada was among the first countries globally to amend its patent law, which resulted in Canada's Access to Medicines Regime (CAMR). …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Texto
  6. 8426
    “…C. muris-infected mice showed high levels of oocysts excretion, whatever the chemical immunosuppression status. Pre-patent periods were 11 days and 9.7 days in average in Dex treated and untreated mice, respectively. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Texto
  7. 8427
    “…Herein we present an overview of the recent advancements in identifying potent and selective A(2B) AR agonists reported in scientific and patent literature. These compounds can be classified into adenosine-like and nonadenosine ligands. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Texto
  8. 8428
    “…We compare our predictions with variant “re-classifications” provided by Myriad Genetics, a biotechnology company that holds the patent on BRCA2 genetic testing in the U.S., and with classifications made by an established medical genetics model [1]. …”
    Enlace del recurso
    Enlace del recurso
    Texto
  9. 8429
    por Lehmann, Birka
    Publicado 2008
    “…The Community as funds for research into medicinal products for the paediatric population shall be provided for in the Community budget in order to support studies relating to medicinal products or active substances not covered by a patent or a supplementary protection certificate. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Texto
  10. 8430
    “…Overall, the most common findings in all patients were: patent foramen ovale (21.7%), previously undiagnosed valvular disease (15.8%), aortic plaques, aortic valve sclerosis, atrial septal aneurysms, regional myocardial dyskinesia, dilated left atrium and atrial septal defects. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Texto
  11. 8431
    “…In the high endemic area, egg-patent schistosomiasis and urinary tract pathology were much more common (p = 1 × 10(-3), 8 × 10(-6), respectively) in comparison with the low endemic area. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Texto
  12. 8432
  13. 8433
    “…METHODS: Three purified recombinant proteins produced in Escherichia coli (GST-MSP1(19), His(6)-MSP1(19 )and His(6)-MSP1(19)-PADRE) and one in Pichia pastoris (yMSP1(19)-PADRE) were compared for their ability to bind to IgG antibodies of individuals with patent P. vivax infection. The method was tested with 200 serum samples collected from individuals living in the north of Brazil in areas endemic for malaria, 53 serum samples from individuals exposed to Plasmodium falciparum infection and 177 serum samples from individuals never exposed to malaria. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Texto
  14. 8434
    por Sharma, Ridhima, Srivastava, Anurag
    Publicado 2010
    “…The pulp width and length from radiographs of 6 selected teeth, namely, maxillary central incisor, lateral incisor, and second premolar and mandibular lateral incisor, canine, and first premolar of either right or left side were measured using the RVG trophy software [Trophy® Windows is a software program supplied by Trophy Radiologie (Trophy Windows Version 5.03, Copyright 1993-2002,Trophy RVG patented by Trophy, Chicago)]. In order to compensate for the differences in magnification and angulation, various ratios were calculated and the mean of all ratios (M) was taken as the first predictor, while the difference between the mean of 2 width ratios and the mean of 2 length ratios (W – L) was taken as the second predictor. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Texto
  15. 8435
    “…All grafts were successfully implanted, and all were patent with intact anastomoses at autopsy. Mean aortic clamp time for each group was as follows: acute, 92.9±28.04 minutes; survival, 59.6±13.8 minutes; P=0.0008. …”
    Enlace del recurso
    Enlace del recurso
    Texto
  16. 8436
    “…During follow-up (mean: 15.2 months, range: 3-24 months), the veins were patent in 74 (67%) limbs. Thirty seven limbs (32%) showed progression of the stenosis with luminal narrowing more than 50%, including three with rethrombosis, while one revealed an asymptomatic iliac vein occlusion; 25 limbs (22%) developed mild post-thrombotic syndrome, and none had severe post-thrombotic syndrome. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Texto
  17. 8437
    “…Infants exposed to lower levels of oxygen (targeting oxygen saturations of <90%) in the first weeks of life are at increased risk of death, cerebral palsy, patent ductus arteriosus, pulmonary vascular resistance and apnoea, whilst those maintained in higher levels of oxygen (targeting oxygen saturations of >90%) have been reported to have greater rates of morbidity including retinopathy of prematurity and chronic lung disease. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Texto
  18. 8438
    “…In the PfAMA1 vaccinated control group, five out of six animals had to be treated with antimalarials 8 days after challenge; one animal did not become patent during the challenge period. Following a rest period, animals were boosted and challenged again. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Texto
  19. 8439
    “…DNDi and sanofi-aventis joined forces in 2004, with the objective of developing within the shortest possible time frame a non-patented, affordable and easy to use fixed-dose combination of artesunate and amodiaquine adapted to the needs of patients, in particular, those of children. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  20. 8440
Herramientas de búsqueda: RSS